前往化源商城

Bioorganic & Medicinal Chemistry Letters 2006-06-15

Development of lipopeptides for inhibiting 20S proteasomes.

Nicolas Basse, David Papapostolou, Maurice Pagano, Michèle Reboud-Ravaux, Elise Bernard, Anne-Sophie Felten, Régis Vanderesse

文献索引:Bioorg. Med. Chem. Lett. 16 , 3277-81, (2006)

全文:HTML全文

摘要

Proteasomes are responsible for the cytoplasmic turnover of the vast majority of proteins including regulatory proteins. We have synthesized lipopeptides a new class of non-covalent inhibitors of the 20S proteasome and assayed their inhibitory capacities. Their ability to inhibit at micromolar concentrations chymotrypsin-like and post-acid activities depends on peptide length (3 or 6 amino acids), sequence (presence of a positively or negatively charged amino acid), and alkyl chain length (C6-C18). These structural features could be varied to selectively inhibit one or more of the three proteasome activities.

相关化合物

结构式 名称/CAS号 全部文献
棕榈酸甲酯 结构式 棕榈酸甲酯
CAS:112-39-0
2-氨基十六烷酸 结构式 2-氨基十六烷酸
CAS:7769-79-1